Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database. - Zhang H; Zhou Z; Wang J; Wang S; Ren J; Zhang M; Yang M (Frontiers in immunology, 2025)